HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?

AbstractINTRODUCTION:
Current National Comprehensive Cancer Network guidelines recommend neoadjuvant therapy for borderline resectable pancreatic adenocarcinoma to increase the likelihood of achieving R0 resection. A consensus has not been reached on the degree of venous involvement that constitutes borderline resectability. This study compares the outcome of patients who underwent pancreaticoduodenectomy with or without vein resection without neoadjuvant therapy.
METHODS:
A multi-institutional database of patients who underwent pancreaticoduodenectomy was reviewed. Patients who required vein resection due to gross vein involvement by tumor were compared to those without evidence of vein involvement.
RESULTS:
Of 492 patients undergoing pancreaticoduodenectomy, 70 (14 %) had vein resection and 422 (86 %) did not. There was no difference in R0 resection (66 vs. 75 %, p = NS). On multivariate analysis, vein involvement was not predictive of disease-free or overall survival.
CONCLUSION:
This is the largest modern series examining patients with or without isolated vein involvement by pancreas cancer, none of whom received neoadjuvant therapy. Oncological outcome was not different between the two groups. These data suggest that up-front surgical resection is an appropriate option and call into question the inclusion of isolated vein involvement in the definition of "borderline resectable disease."
AuthorsKaitlyn J Kelly, Emily Winslow, David Kooby, Neha L Lad, Alexander A Parikh, Charles R Scoggins, Syed Ahmad, Robert C Martin, Shishir K Maithel, H J Kim, Nipun B Merchant, Clifford S Cho, Sharon M Weber
JournalJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (J Gastrointest Surg) Vol. 17 Issue 7 Pg. 1209-17; discussion 1217 (Jul 2013) ISSN: 1873-4626 [Electronic] United States
PMID23620151 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adenocarcinoma (pathology, surgery)
  • Aged
  • Female
  • Humans
  • Male
  • Mesenteric Veins (surgery)
  • Middle Aged
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms (pathology, surgery)
  • Pancreaticoduodenectomy
  • Portal Vein (surgery)
  • Retrospective Studies
  • Vascular Neoplasms (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: